BVS — Bioventus Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual balance sheet for Bioventus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	43.9	30.2	37	41.6	51.2
Net Total Accounts Receivable
Net Total Receivables	125	137	123	127	128
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	263	273	268	276	273
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	40.2	44.1	50	33.5	27
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,226	1,373	811	728	684
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	181	304	175	210	160
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	767	1,047	637	580	499
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	459	325	174	148	184
Total Liabilities & Shareholders' Equity	1,226	1,373	811	728	684
Total Common Shares Outstanding